Evolus, Inc. (EOLS) stock
EOLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.96−0.22 (-3.06%)
Close on Nov 13, 2026Market cap $459.71MP/E –Yield –
Evolus enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Evolus's enterprise value was $601.40M on Nov 11, 2026, against $565.98M a year earlier. Over the last 5 years it ranged from $253.86M to $960.98M, with a median of $532.95M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $601.40M | +12.8% |
| 2025 | Dec 31, 2025 | $532.95M | -13.1% |
| 2024 | Dec 31, 2024 | $613.26M | +9.0% |
| 2023 | Dec 29, 2023 | $562.50M | +57.8% |
| 2022 | Dec 30, 2022 | $356.37M | +40.4% |
| 2021 | Dec 31, 2021 | $253.86M | +7652.8% |
| 2020 | Dec 31, 2020 | $3.27M | -99.0% |
| 2019 | Dec 31, 2019 | $332.92M | +40.9% |
| 2018 | Dec 31, 2018 | $236.20M | – |
See a number that looks wrong?